This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
I suspect that I don't eat quite enough calcium, but that TX pushed me way over the edge. If I hadn't been heavily into exercise it could be worse. There are a few threads on the board here about it, back in 1999 or so.
Here is a link to one study that points the finger and Ribavirin more than Interferon. In case you aren't familiar with the ranges, normal is -1 to 1. Osteopenia is -1 to -2.5. Less than -2.5 is Osteoporosis when fractures can occur spontaneously, after small bumps and so on. As far as I can see there aren't a lot of reports of fractures. The study says almost all subjects on IFN/Riba combination therapy experienced bone density loss.
http://www.natap.org/2008/HCV/022008_02.htm
For those that are currently treating there might be something that can be done to minimise it. At least have a couple of bone scans to see what is going on. Age obviously makes a difference. I am 52 and female so menopause also contributes to the problem. Even so, my doctor was shocked and said she wanted to know why it was so bad for my age. I went home and started looking too. That's when I started finding out the probable cause.
From my point of view I want to know if I can reverse it. Curious to know if people have had bone scans after treatment and tried to improve/measure the situation.
I was aware of this problem during treatment and had the scan done. Fortunately it came out normal.
I remember coming across a study some time ago saying that successful treatment had actually helped with the bone density. So with SVR one could actually help this problem, too.
I didn't look further into any treatments of this, as I had good results.
I was dx with osteopenia a month before I started treatment for C and began taking fosamax weekly - the low dose 35 mg per week. Before tx for C my hip T score was -1.7. After treatment my T score was -1.3, so it did improve. The lumbar spine T score imporved during that time too. I continued to take the fosamax thoughout my tx and did not clear the virus, so would surmise the improvement was from the fosamax and not anything else.
So yes, there is a way to reverse your bone loss and I am surprised your doctor has not suggested fosamax or the generic equivalent.
frijole
I didn't (and can't) say that TX was entirely responsible. I think it was likely to have been a significant contributing factor. I had no idea about the bone density loss issue until now. I would have liked to have had it monitored/managed in association with treatment while I was undergoing it not find out afterwards.
Here is the abstract for the study you refer to:
http://pt.wkhealth.com/pt/re/jvhp/abstract.00043778-200811000-00003.htm
Unfortunately there is no information about sponsors and collaborators on the above Web page. I haven't paid to retrieve the details of the study. It is hard to know from that small amount of information whether to take it seriously or not. It does seem rather optimistic. It seems that they stating that treatment actually increases bone mineral density while you are treating. They state that the improvement might presist after successful treatment, but BMD decreases to previous levels on relapse. That is opposite to everything else I have seen and heard which is curious.
I favour the study by the University of Ulm (the first link) because they have made an effort to rule out influences such as menopause, and they have compared IFN versus Riba. I'd certainly like to know why the results can be so completely opposite.
Either way, for people treating or considering doing so, it wouldn't hurt to check BMD.
Susan400
I am certainly going to try to reverse it. People have been telling me that it is very hard/impossible to reverse. I won't accept that until I have given it a good try.
Good luck to you too. I hope your exercise/diet help. Did you get advice about that? Did anyone mention Fosamax to you? My doctor didn't. She told me to up my calcium to 1300 mg per day, every day. She is waiting for the Vit. D test before commenting on that. Still in the middle of a round of tests at the moment.
You are amazing... still standing after treating 10 times!
After a few more days of reading and seeing people's input it seems like HCV contributes to bone mineral density loss but Ribavirin makes it worse. I had absolutely no idea about this either. Interesting that some doctors are onto the problem and it isn't on the radar for others. It makes sense that problems with teeth are related too. TX causes significant BMD loss in men too. I am thinking if I already have osteopenia now and am recently menopausal I am looking at some serious issues some years down the track. I like my (slightly) rough and tumble sport. Don't want to be carried out of the forrest on a stretcher.
Further interesting info:
Susan400 posted this link last year:
http://www.hivandhepatitis.com/2008icr/ddw/docs/060308_b.html
and frijole posted this from Melissa Palmer, MD:
http://liverdisease.com/womenhcv.html
OSTEOPOROSIS
Osteoporosis is a condition characterized by decreased bone mass and decreased bone density. This leads to a weakening of bones, thereby increasing the risk of bone pain and bone fractures. Some liver experts believe that ribavirin may cause or worsen osteoporosis.
Women are at higher risk for the development of osteoporosis than men. Post-menopausal women are particularly susceptible to osteoporosis because, as estrogen production stops, bone loss accelerates. In addition, women naturally have a lower percentage of muscle and bone mass than men. This further increases their risk of developing osteoporosis.
Finally, lack of activity resulting from excessive fatigue as well as poor nutritional habits while on therapy further puts women at risk for osteoporosis
All women with HCV especially postmenopausal women, and women with cirrhosis should undergo bone-mineral-density testing in order to determine whether they have osteoporosis. Blood tests, by themselves, are an insufficient means of measuring bone density and calcium requirements.
There are some steps that can be taken to reduce the likelihood of osteoporosis. Women should supplement their diets with calcium (1,000 to 2,000 milligrams per day) and vitamin D (400 to 800 IU per day). Also, an exercise routine, including weight-bearing exercises, must be incorporated into one’s lifestyle. Weight-bearing exercises not only increase muscle size, but they increase underlying bone mass, thus decreasing the likelihood of osteoporosis. Smoking, alcohol, and excessive caffeine should be avoided as these factors may worsen osteoporosis
Estrogen-hormonal therapy has been demonstrated to increase bone mass. However, oral estrogen replacement should generally be avoided in women with HCV, as it may cause additional liver problems, such as worsening of cholestasis. Furthermore, estrogen supplementation may cause certain benign liver tumors, such as hemangiomas and/or hepatic adenomas, which are more common in women to enlarge. Estrogen patches are generally a safer choice. Implantable estrogen, a recent development, is probably safe, but long-term studies as to its effect on liver disease have not been done. Soy estrogen, originally thought to be a safe alternative, should be avoided, as recent reports have suggested that it may cause drug-induced hepatitis.
Biphosphonates are phosphate derivatives that bind to the surface of the bone, thereby blocking bone removal and decreasing bone loss. Currently, there are three biphosphonates - alendronate [Fosamax], etidronate [Didronal]) and risedronate [Actonel], that have been approved by the FDA for the prevention and treatment of osteoporosis. These medications have been shown to increase bone mass, prevent bone loss, and to decrease the incidence of bone fractures. Fosamax and Actonal have the advantage of a once-a-week administration, as opposed to the alternative of daily administration. Biphosphonates should be taken on an empty stomach, along with at least 8 ounces of water. The patient should swallow the tablet while in an upright position and not lie down for 30 minutes after taking this drug. Calcium should not be taken at the same time. Women at high risk for osteoporosis with HCV with may benefit from starting biphosphonate therapy before they develop osteoporosis. Any woman who already has osteoporosis should begin biphosphonate therapy promptly. However, women with esophageal varices should probably avoid these medications because of the drug’s capability to cause ulcers in the esophagus, which may precipitate esophageal variceal hemorrhage. Calcitonin (Miacalcin) is a hormone produced by the thyroid gland that decreases the release of calcium from the bones. Calcitonin has been shown to reduce the incidence of bone fractures and bone loss in postmenopausal women with osteoporosis. Synthetic calcitonin, known as miacalcin, is FDA approved for the treatment of osteoporosis. When sprayed into the nose, miacalcin is quickly absorbed into the blood stream. It may be also be taken as a subcutaneous injection. Miacalcin has also been shown to decrease bone pain associated with bone fractures caused by osteoporosis. In addition, it appears to be quite beneficial in preventing bone loss after liver transplantation. Thus, miacalcin can be an effective alternative for women who do not wish to take, or are unable to take, bisphosphonates.
All contents of this article are Copyright © Melissa Palmer, MD
frijole
http://www.ftrdergisi.com/eng/yazilar.asp?yaziid=101&sayiid=
I find this one interesting because it suggests that the bone mineral density loss is greater in the lumbar region of the spine during treatment. My personal results support that. There is a quite a difference between the hip (-1.4) and spine (-2.0) T-scores. Although that result isn't definitive it seems pretty significant given approximate rates of difference to be expected are 54% concordance, 42% minor dischordance, and 4% major dischordance. (Major dischordance is classified as 1.0 unit difference between lumbar and hip T-scores.)
The study checked for malabsorption of calcium and vitamin D deficiency as possible causes, they couldn't find significant differences between the control and treating groups using their selected markers. They therefore suggest that some other mechanism is likely to be causing the loss and that it may be related to differing concentrations of the two types of tissue that form bones. They suggest the spongy bits (cancellous bone) not the hard outer layer (cortical bone) might be getting trounced. Interesting.
Thanks for starting this thread....lots of good information to reference once I get my results.
Please keep us updated.on your condition
Isobella